Page last updated: 2024-09-02

exp3174 and Alloxan Diabetes

exp3174 has been researched along with Alloxan Diabetes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baik, EJ; Jung, YS; Lee, HJ; Lee, SH; Moon, CH	1

Other Studies

1 other study(ies) available for exp3174 and Alloxan Diabetes

Article	Year
Pharmacokinetics of losartan and its metabolite, EXP3174, after intravenous and oral administration of losartan to rats with streptozotocin-induced diabetes mellitus. Research communications in molecular pathology and pharmacology, 1998, Volume: 101, Issue:2 Topics: Administration, Oral; Animals; Antihypertensive Agents; Area Under Curve; Blood Glucose; Blood Proteins; Diabetes Mellitus, Experimental; Half-Life; Imidazoles; Injections, Intravenous; Losartan; Metabolic Clearance Rate; Rats; Rats, Sprague-Dawley; Tetrazoles	1998

Article

Year

Pharmacokinetics of losartan and its metabolite, EXP3174, after intravenous and oral administration of losartan to rats with streptozotocin-induced diabetes mellitus.

Research communications in molecular pathology and pharmacology, 1998, Volume: 101, Issue:2

Topics: Administration, Oral; Animals; Antihypertensive Agents; Area Under Curve; Blood Glucose; Blood Proteins; Diabetes Mellitus, Experimental; Half-Life; Imidazoles; Injections, Intravenous; Losartan; Metabolic Clearance Rate; Rats; Rats, Sprague-Dawley; Tetrazoles

1998